• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘吸入器与牙釉质表层下脱矿:一项原位初步研究。

Asthma inhalers and subsurface enamel demineralisation: an in situ pilot study.

作者信息

Tootla R, Kotru G, Connolly M A, Duggal M S, Toumba K J

机构信息

Dept. Paediatric Dentistry, Leeds Dental Institute, England.

出版信息

Eur J Paediatr Dent. 2005 Sep;6(3):139-43.

PMID:16216094
Abstract

AIM

The purpose of this pilot study was to identify the subsurface enamel demineralising potential of two possible acidogenic lactose-based powders and their corresponding generic pump inhalers.

METHODS

Ten healthy non-asthmatic adults participated in a 5- leg randomised crossover study including a 10% sucrose control. A twice-daily 400 microg dose of inhaler was applied in vitro to a demineralised enamel slab on the buccal flange of a mandibular removable appliance before in situ placement for 14 days each. Lesion parameters were determined using transverse microradiography and digitised image analysis.

RESULTS

Minimal demineralisation occurred with sucrose, both pump and one powder inhaler. The remaining powder was associated with remineralisation (p = 0.29). Overall, mean lesion depth increased (p = 0.12).

CONCLUSION

Asthma inhalers failed to demonstrate a significant acidogenic/cariogenic effect.

摘要

目的

本初步研究的目的是确定两种可能产酸的乳糖基粉末及其相应的普通泵式吸入器对牙釉质表面下脱矿的潜在影响。

方法

10名健康的非哮喘成年人参与了一项包含5个阶段的随机交叉研究,其中包括10%蔗糖对照。每天两次400微克剂量的吸入器在体外应用于下颌可摘矫治器颊侧翼缘的脱矿牙釉质板上,然后原位放置14天。使用横向显微放射照相术和数字化图像分析确定病变参数。

结果

蔗糖、泵式吸入器和一种粉末吸入器导致的脱矿作用最小。剩余的粉末与再矿化有关(p = 0.29)。总体而言,平均病变深度增加(p = 0.12)。

结论

哮喘吸入器未显示出显著的产酸/致龋作用。

相似文献

1
Asthma inhalers and subsurface enamel demineralisation: an in situ pilot study.哮喘吸入器与牙釉质表层下脱矿:一项原位初步研究。
Eur J Paediatr Dent. 2005 Sep;6(3):139-43.
2
Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.通过联合使用都保吸入器给药的沙美特罗和丙酸氟替卡松(50/250微克):与通过单独的都保吸入器给药时效果相同。
Can Respir J. 1999 Jan-Feb;6(1):45-51. doi: 10.1155/1999/894803.
3
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.布地奈德/福莫特罗压力定量吸入器与氟替卡松/沙美特罗干粉吸入器及沙丁胺醇压力定量吸入器相比的早期支气管扩张作用:两项针对曾接受吸入性糖皮质激素治疗的持续性哮喘成年患者的随机对照试验。
J Asthma. 2008 May;45(4):265-72. doi: 10.1080/02770900801890505.
4
Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.丙酸氟替卡松和沙美特罗联合干粉吸入剂(胶囊型和多剂量型)在哮喘和 COPD 患者中的药代动力学和药效学。
J Aerosol Med Pulm Drug Deliv. 2014 Aug;27(4):279-89. doi: 10.1089/jamp.2013.1040. Epub 2013 Sep 28.
5
Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.哮喘患者使用可调节剂量和固定剂量的布地奈德/福莫特罗压力定量吸入器与固定剂量的丙酸氟替卡松/沙美特罗干粉吸入器治疗期间患者报告结局的比较。
J Asthma. 2010 Mar;47(2):217-23. doi: 10.3109/02770900903497154.
6
Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.
Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):527-34. doi: 10.1164/ajrccm.161.2.9905091.
7
Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propionate 250 microg: implications for establishing bioequivalence of inhaled products.两项针对哮喘患者的随机双盲研究以及一项比较两种递送50微克沙美特罗和250微克丙酸氟替卡松组合的干粉吸入器的体外研究的药代动力学、药效学、疗效和安全性数据:对确定吸入产品生物等效性的意义。
Clin Ther. 2009 Feb;31(2):370-85. doi: 10.1016/j.clinthera.2009.02.007.
8
Contamination of dry powder inhalers for asthma with milk proteins containing lactose.含乳糖的牛奶蛋白对哮喘用干粉吸入器的污染。
J Allergy Clin Immunol. 2004 Mar;113(3):558-60. doi: 10.1016/j.jaci.2003.11.015.
9
Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.定量气雾剂和新型干粉吸入器吸入沙丁胺醇后支气管扩张反应的初步研究
Ann Allergy Asthma Immunol. 1997 Oct;79(4):322-6. doi: 10.1016/S1081-1206(10)63022-0.
10
Comparative pulmonary function and pharmacokinetics of fluticasone propionate and salmeterol xinafoate delivered by two dry powder inhalers to patients with asthma.丙酸氟替卡松和沙美特罗替卡松经两种干粉吸入器给药治疗哮喘患者的肺功能和药代动力学比较。
J Aerosol Med Pulm Drug Deliv. 2011 Oct;24(5):245-52. doi: 10.1089/jamp.2011.0884. Epub 2011 Jun 14.

引用本文的文献

1
Evaluation of cariogenic potential of dry powder inhalers: A case-control study.干粉吸入器致龋潜力的评估:一项病例对照研究。
Lung India. 2013 Apr;30(2):113-6. doi: 10.4103/0970-2113.110418.